JP2020509786A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020509786A5 JP2020509786A5 JP2020500024A JP2020500024A JP2020509786A5 JP 2020509786 A5 JP2020509786 A5 JP 2020509786A5 JP 2020500024 A JP2020500024 A JP 2020500024A JP 2020500024 A JP2020500024 A JP 2020500024A JP 2020509786 A5 JP2020509786 A5 JP 2020509786A5
- Authority
- JP
- Japan
- Prior art keywords
- promoter
- nucleic acid
- seq
- group
- expression vector
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000007523 nucleic acids Chemical class 0.000 claims 24
- 239000013604 expression vector Substances 0.000 claims 13
- 241000702423 Adeno-associated virus - 2 Species 0.000 claims 12
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 12
- 239000000203 mixture Substances 0.000 claims 10
- 241001634120 Adeno-associated virus - 5 Species 0.000 claims 8
- 241000972680 Adeno-associated virus - 6 Species 0.000 claims 8
- 241001164823 Adeno-associated virus - 7 Species 0.000 claims 8
- 241001164825 Adeno-associated virus - 8 Species 0.000 claims 8
- 241000701024 Human betaherpesvirus 5 Species 0.000 claims 8
- 108020004707 nucleic acids Proteins 0.000 claims 8
- 102000039446 nucleic acids Human genes 0.000 claims 8
- 239000013603 viral vector Substances 0.000 claims 8
- 210000004027 cell Anatomy 0.000 claims 7
- 101000798700 Homo sapiens Transmembrane protease serine 3 Proteins 0.000 claims 6
- 206010011878 Deafness Diseases 0.000 claims 5
- 101000798702 Homo sapiens Transmembrane protease serine 4 Proteins 0.000 claims 5
- 230000010370 hearing loss Effects 0.000 claims 5
- 231100000888 hearing loss Toxicity 0.000 claims 5
- 208000016354 hearing loss disease Diseases 0.000 claims 5
- 230000035772 mutation Effects 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 102000007469 Actins Human genes 0.000 claims 4
- 108010085238 Actins Proteins 0.000 claims 4
- 241001655883 Adeno-associated virus - 1 Species 0.000 claims 4
- 241000202702 Adeno-associated virus - 3 Species 0.000 claims 4
- 241000580270 Adeno-associated virus - 4 Species 0.000 claims 4
- 241000701022 Cytomegalovirus Species 0.000 claims 4
- 241000287828 Gallus gallus Species 0.000 claims 4
- 102000026889 Myosin VIIa Human genes 0.000 claims 4
- 108010009047 Myosin VIIa Proteins 0.000 claims 4
- 102100032454 Transmembrane protease serine 3 Human genes 0.000 claims 4
- 101150016977 pou4f3 gene Proteins 0.000 claims 4
- 210000001062 endolymphatic sac Anatomy 0.000 claims 2
- 230000002068 genetic effect Effects 0.000 claims 2
- 238000002347 injection Methods 0.000 claims 2
- 239000007924 injection Substances 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 101100343697 Homo sapiens LOXHD1 gene Proteins 0.000 claims 1
- 101001043326 Homo sapiens Lipoxygenase homology domain-containing protein 1 Proteins 0.000 claims 1
- 210000003027 ear inner Anatomy 0.000 claims 1
- 210000004263 induced pluripotent stem cell Anatomy 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 210000002480 semicircular canal Anatomy 0.000 claims 1
- 238000011830 transgenic mouse model Methods 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762472790P | 2017-03-17 | 2017-03-17 | |
| US62/472,790 | 2017-03-17 | ||
| US201762531522P | 2017-07-12 | 2017-07-12 | |
| US62/531,522 | 2017-07-12 | ||
| PCT/US2018/022873 WO2018170402A1 (en) | 2017-03-17 | 2018-03-16 | Gene therapy constructs and methods for treatment of hearing loss |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020509786A JP2020509786A (ja) | 2020-04-02 |
| JP2020509786A5 true JP2020509786A5 (enExample) | 2021-03-11 |
Family
ID=63522674
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020500024A Pending JP2020509786A (ja) | 2017-03-17 | 2018-03-16 | 聴覚損失の治療のための遺伝子治療構成物および方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20200248203A1 (enExample) |
| EP (1) | EP3595634B1 (enExample) |
| JP (1) | JP2020509786A (enExample) |
| KR (1) | KR102752457B1 (enExample) |
| CN (1) | CN110709060A (enExample) |
| BR (1) | BR112019019367A2 (enExample) |
| CA (1) | CA3054941A1 (enExample) |
| ES (1) | ES2982270T3 (enExample) |
| IL (1) | IL268912B2 (enExample) |
| WO (1) | WO2018170402A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12391936B2 (en) | 2017-03-17 | 2025-08-19 | Rescue Hearing, Inc. | Gene therapy systems and related methods for treatment of hearing loss |
| WO2020077295A1 (en) | 2018-10-11 | 2020-04-16 | Decibel Therapeutics, Inc. | Aav1 vectors and uses thereof for treatment of otic indications |
| CN112442528B (zh) * | 2019-08-30 | 2022-08-12 | 深圳华大基因股份有限公司 | Loxhd1基因突变体及其应用 |
| CN116096391A (zh) * | 2020-02-05 | 2023-05-09 | 援救听觉股份有限公司 | 用于治疗听力损失的基因疗法系统和相关方法 |
| EP4008788A1 (en) * | 2020-12-03 | 2022-06-08 | Medizinische Hochschule Hannover | Lentiviral vector technology for inner ear gene therapy |
| CN113584082B (zh) * | 2021-06-22 | 2023-07-25 | 复旦大学附属眼耳鼻喉科医院 | CRISPR/Cas9基因编辑系统及其在制备治疗遗传性感音神经性聋的药物中的应用 |
| CN113215248B (zh) * | 2021-06-25 | 2022-04-22 | 中国人民解放军空军军医大学 | 一种感音神经性耳聋相关的myo15a基因突变检测试剂盒 |
| CN121568725A (zh) * | 2023-06-15 | 2026-02-24 | 里珍纳龙药品有限公司 | 用于听力病症的基因疗法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1280923A2 (en) * | 2000-04-28 | 2003-02-05 | Millennium Pharmaceuticals, Inc. | 14094, a human trypsin family member and uses thereof |
| WO2004099779A1 (en) * | 2003-05-05 | 2004-11-18 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 3 (tmprss3) |
| AU2006280321A1 (en) * | 2005-08-15 | 2007-02-22 | Genentech, Inc. | Gene disruptions, compositions and methods relating thereto |
| WO2011075838A1 (en) * | 2009-12-21 | 2011-06-30 | Audigen Inc. | Method of treating or preventing hearing loss |
| US20150050354A1 (en) * | 2012-04-02 | 2015-02-19 | Moderna Therapeutics, Inc. | Modified polynucleotides for the treatment of otic diseases and conditions |
| JP2015527889A (ja) | 2012-07-25 | 2015-09-24 | ザ ブロード インスティテュート， インコーポレイテッド | 誘導可能なｄｎａ結合タンパク質およびゲノム撹乱ツール、ならびにそれらの適用 |
| WO2015048577A2 (en) | 2013-09-27 | 2015-04-02 | Editas Medicine, Inc. | Crispr-related methods and compositions |
| NZ718926A (en) | 2013-10-11 | 2021-12-24 | Massachusetts Eye & Ear Infirmary | Methods of predicting ancestral virus sequences and uses thereof |
| WO2015175642A2 (en) * | 2014-05-13 | 2015-11-19 | Sangamo Biosciences, Inc. | Methods and compositions for prevention or treatment of a disease |
| EP3212221B1 (en) | 2014-10-29 | 2023-12-06 | Massachusetts Eye & Ear Infirmary | Efficient delivery of therapeutic molecules in vitro and in vivo |
| CN116236591B (zh) * | 2015-12-11 | 2026-02-27 | 马萨诸塞眼科耳科诊所 | 用于将核酸递送至耳蜗和前庭细胞的材料和方法 |
-
2018
- 2018-03-16 CN CN201880028001.3A patent/CN110709060A/zh active Pending
- 2018-03-16 US US16/488,103 patent/US20200248203A1/en active Pending
- 2018-03-16 EP EP18768248.9A patent/EP3595634B1/en active Active
- 2018-03-16 IL IL268912A patent/IL268912B2/en unknown
- 2018-03-16 WO PCT/US2018/022873 patent/WO2018170402A1/en not_active Ceased
- 2018-03-16 JP JP2020500024A patent/JP2020509786A/ja active Pending
- 2018-03-16 CA CA3054941A patent/CA3054941A1/en active Pending
- 2018-03-16 ES ES18768248T patent/ES2982270T3/es active Active
- 2018-03-16 KR KR1020197030012A patent/KR102752457B1/ko active Active
- 2018-03-16 BR BR112019019367A patent/BR112019019367A2/pt unknown
-
2019
- 2019-12-24 US US16/726,495 patent/US20200114023A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021511803A5 (enExample) | ||
| CN105408352B (zh) | 通过双重aav载体有效递送大基因 | |
| CN109844124B (zh) | 年龄相关疾病和病症的基因治疗方法 | |
| JP2022508182A5 (enExample) | ||
| KR102527259B1 (ko) | 스터퍼/필러 폴리누클레오티드 서열을 포함하는 벡터 및 사용 방법 | |
| AU2019250249A1 (en) | Promoters, expression cassettes, vectors, kits, and methods for the treatment of achromatopsia and other diseases | |
| JP2021512649A5 (enExample) | ||
| AU2022201920A1 (en) | Adeno-associated virus mediated delivery of C1EI as a therapy for angioedema | |
| IL292999A (en) | Compositions and methods of treating amyotrophic lateral sclerosis (als) | |
| TW201629225A (zh) | 第九因子基因療法 | |
| FI3628334T3 (fi) | Geenihoito verkkokalvon pigmenttirappeuma | |
| JP2020054367A (ja) | 改変ｇ６ｐｃをコードするアデノ随伴ウイルスベクターおよびその使用 | |
| CN113557243A (zh) | 用于神经变性疾病的基因疗法 | |
| JP2017529395A5 (enExample) | ||
| JP2021510301A5 (enExample) | ||
| HRP20241483T1 (hr) | Sastavi i postupci za liječenje poremećaja mrežnice | |
| CN119403823A (zh) | 具有增强的肌肉转导效率的肽修饰的aav衣壳 | |
| US20210180084A1 (en) | Gene therapy vectors comprising s/mar sequences | |
| CN114144518A (zh) | 用于基因疗法的双亮氨酸拉链激酶抑制剂 | |
| JP2022548270A5 (enExample) | ||
| EP3302540B1 (en) | Adeno-associated virus mediated delivery of c1ei as a therapy for angioedema | |
| JP2018536432A5 (enExample) | ||
| US20250135033A1 (en) | Compositions and methods for treating sialidosis | |
| JP2024515629A5 (enExample) | ||
| KR102874560B1 (ko) | 아데노연관바이러스 변이체 |